Arcturus Therapeutics is trading 10.3% up at $16.28, rebounding from its August 31, 2026 close of $14.76 with the immediate driver unclear.
- The latest company announcement concerned upcoming investor conferences beginning September 8, 2026.
- Recent searches found no new approval, earnings update, partnership, or other direct trigger.
- The rebound came despite broader market weakness and a 4.24% decline in biotech.